How dangerous are India’s generic drugs? Very


India relies on the weak oversight of developing countries that make up the bulk of its exports – that’s how it can continue to push substandard and often deadly medicines there. — Bloomberg

FOR a nation that seeks to claim the mantle of “pharmacy to the world,” India is scandalously short on regulatory oversight.

In the last six months, its generic cough syrups have killed dozens of children, its eye drops have caused blindness and its chemotherapy drugs have been contaminated.

Save 30% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 9.73/month

Billed as RM 9.73 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 8.63/month

Billed as RM 103.60 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
India , genericdrugs , regulation , oversight , scandals

Next In Business News

Medtronic partners with Neuralink rival Precision for brain tech
Foodie Media� 1Q revenue at RM13mil
Oil nudges up on Iran risk premium
Stable�medium-term outlook�for CPO prices
Kumpulan Jetson in RM15mil sale
Healthcare sector rerating likely on big-ticket IPOs�
Rimbunan Sawit disposes Sarawak asset
5E Resources gets Bursa’s nod for ACE Market listing
Pricing deal to avoid EU tariffs on Chinese EVs
Vietnam steps up price controls before New Year

Others Also Read